---
title: "Healthcare Data Interoperability Vendors: The FHIR API Maturity Test"
keywords: "healthcare data interoperability vendor, FHIR API maturity, health data exchange vendor selection, interoperability platform due diligence, healthcare API vendor comparison"
buyer_stage: "Decision"
target_persona: "CTO"
---

# Healthcare Data Interoperability Vendors: The FHIR API Maturity Test

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "headline": "Healthcare Data Interoperability Vendors: The FHIR API Maturity Test",
  "description": "A CTO's framework for evaluating healthcare data interoperability vendors on TEFCA readiness, FHIR maturity levels, and real payer and provider network participation, not aggregator marketing claims.",
  "author": {"@type": "Organization", "name": "Manifera", "url": "https://www.manifera.com/"},
  "publisher": {"@type": "Organization", "name": "Manifera", "url": "https://www.manifera.com/"},
  "datePublished": "2026-09-08",
  "mainEntityOfPage": {"@type": "WebPage", "@id": "https://www.manifera.com/blog/healthcare-data-interoperability-vendors-the-fhir-api-maturity-test"}
}
</script>

There's a meaningful difference between a vendor who integrates with "10,000+ healthcare organizations" and one who can tell you, specifically, whether that network access runs through direct FHIR endpoints, an HL7 v2 translation layer they operate behind the scenes, or a data broker relationship with uneven data freshness across sources. The marketing number is the same either way. The engineering reality — and what breaks when your product depends on it in production — is not. Healthcare data interoperability vendors (aggregators and platforms like the Redox, Health Gorilla, 1upHealth, and Particle Health category, as distinct from a single EHR's own integration layer) sell access, but the quality of that access varies enormously underneath a similar-looking API surface.

Evaluating this category requires understanding what's actually happening beneath the API: how current the underlying data connections are, whether the vendor participates in the frameworks shaping where US health data exchange is heading, and how mature their FHIR implementation actually is against the standard's own maturity model.

## The Interoperability Vendor Landscape

Three broad models exist, and vendors often blend them without saying so clearly. Direct integration vendors build and maintain point-to-point connections to specific EHR instances (a specific Epic install, a specific Oracle Health tenant) — highest fidelity, highest maintenance cost, typically the model for vendors serving large health systems directly. Aggregator/network vendors maintain a broad web of pre-built connections and expose a single unified API on top — faster time to market for you, but data freshness and completeness depend entirely on the underlying connection's quality, which varies by source and isn't always transparent. Query-based network vendors (increasingly relevant as TEFCA matures) route requests through a trusted exchange framework rather than maintaining direct connections themselves. Ask any interoperability vendor directly which model applies to which of their advertised connections — a vendor unwilling or unable to answer specifically is likely obscuring uneven underlying quality.

## TEFCA and QHIN Participation as a Signal

The Trusted Exchange Framework and Common Agreement (TEFCA), operationalized through Qualified Health Information Networks (QHINs) designated by the Sequoia Project as Recognized Coordinating Entity, is becoming the backbone for nationwide query-based health data exchange in the US. A vendor's QHIN participation — either operating as a QHIN themselves or connecting through one — is a genuine maturity signal, because it means they've passed a formal onboarding and security review process rather than just claiming broad connectivity. Ask directly whether the vendor participates in TEFCA, through which QHIN, and what exchange purposes (treatment, payment, operations, individual access) they support — this affects what data you can actually request and for what use case, since TEFCA's permitted purposes framework restricts queries by intended use.

## FHIR Maturity Levels Explained

HL7's FHIR Maturity Model (FMM) rates individual FHIR resources and implementations on a 0-6 scale from Draft through Normative, describing how stable and battle-tested a given resource definition is. Separately and more practically for vendor evaluation, assess implementation maturity directly: does the vendor support FHIR R4 with documented US Core profile conformance, or a proprietary variant loosely based on FHIR? Do they support both single-record REST queries and Bulk Data ($export) for population-level use cases? Can they demonstrate a passing Inferno test suite run — ONC's open-source conformance testing tool — for the specific resources your product depends on? A vendor who answers with resource-level specificity ("we support Patient, Observation, and MedicationRequest at full US Core conformance; Condition support is partial") is demonstrably more mature than one who answers "yes, we do FHIR" in the abstract.

## Da Vinci Implementation Guides and Payer Rules

If your product touches payer-side data exchange — prior authorization, coverage information, claims-based data — the Da Vinci Project's implementation guides (CRD, DTR, PAS for prior authorization workflows; PDex for payer data exchange) are the specific technical standards vendors need to support, and they're increasingly mandatory rather than optional. CMS's Interoperability and Prior Authorization Final Rule requires impacted payers to implement specific FHIR-based APIs on defined timelines. A vendor operating in this space should be able to name which Da Vinci IGs they support and at what conformance level — generic FHIR competency doesn't automatically translate to payer-specific implementation guide support, which has its own resource profiles and workflow constraints layered on top of base FHIR.

## Vendor Due Diligence Questions

Beyond the technical maturity test, verify operationally: what's the vendor's documented data latency per source (real-time, near-real-time, or batch-updated overnight)? How do they handle and communicate source outages or connection degradation — proactive status page and alerting, or silent failure discovered by you in production? What's their BAA and subprocessor structure, given that a network vendor by definition routes PHI through infrastructure you don't control directly? And critically, what's their exit path — if you switch vendors, how portable is your integration logic, and are you tied to their proprietary data model or genuinely working against standard FHIR resources you could port elsewhere?

## Making the Call

The vendors worth shortlisting can describe their FHIR maturity, TEFCA participation, and Da Vinci IG support in specifics rather than aggregate connectivity claims — because those specifics are what determine whether your product actually gets reliable data when it matters. Manifera's engineering teams build the application layer on top of these interoperability platforms and have evaluated this vendor category directly across [custom software development](https://www.manifera.com/services/custom-software-development/) engagements for healthcare clients. For the EHR-specific integration questions this article doesn't cover in depth, see our companion piece on [choosing an EHR integration vendor](https://www.manifera.com/blog/choosing-an-ehr-integration-vendor-hl7-fhir-interoperability-test), and for the BAA obligations that apply the moment PHI flows through any interoperability vendor, see [the BAA clauses that actually protect you](https://www.manifera.com/blog/hipaa-compliant-software-vendors-the-baa-clauses-that-actually-protect-you).

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ItemList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position": 1,
      "name": "TEFCA / QHIN Participation",
      "description": "Participation in the Trusted Exchange Framework and Common Agreement through a Qualified Health Information Network signals that a vendor has passed formal onboarding and security review for nationwide, query-based health data exchange, rather than relying only on self-reported connectivity claims."
    },
    {
      "@type": "ListItem",
      "position": 2,
      "name": "Da Vinci Implementation Guides",
      "description": "HL7 FHIR implementation guides — including CRD, DTR, PAS, and PDex — that define payer-specific data exchange workflows like prior authorization and coverage information, increasingly required under CMS interoperability rules and distinct from generic FHIR competency."
    }
  ]
}
</script>

## Frequently Asked Questions

### What's the difference between a direct integration vendor and an aggregator?
A direct integration vendor builds and maintains point-to-point connections to specific EHR instances, offering higher data fidelity but higher maintenance overhead. An aggregator maintains a broad pre-built network and exposes a unified API, offering faster access but with data quality and freshness that varies by underlying source and isn't always transparent to you as the buyer.

### Why does TEFCA participation matter for vendor selection?
TEFCA/QHIN participation requires passing a formal onboarding and security review process through the Sequoia Project's Recognized Coordinating Entity role, making it a more verifiable maturity signal than a vendor's own connectivity claims. It also determines which permitted exchange purposes — treatment, payment, operations — your queries can actually support.

### Is FHIR R4 support enough, or do we need to verify more?
FHIR R4 support alone isn't sufficient verification. You need to confirm US Core profile conformance for the specific resources your product uses, ideally backed by a documented Inferno test suite pass, since generic "FHIR support" claims often mask partial or non-standard resource implementations.

### How do Da Vinci implementation guides relate to standard FHIR?
Da Vinci IGs are built on top of base FHIR but add payer-specific resource profiles and workflow constraints for use cases like prior authorization and coverage data exchange. A vendor's general FHIR competency doesn't automatically mean they support specific Da Vinci IGs like PAS or PDex at a usable conformance level.

### What happens to our integration if we switch interoperability vendors later?
Portability depends on whether the vendor exposed genuinely standard FHIR resources or a proprietary data model layered on top of FHIR. Ask vendors directly about this before committing, since a proprietary abstraction layer can make switching vendors later far more expensive than the initial integration suggested.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What's the difference between a direct integration vendor and an aggregator?",
      "acceptedAnswer": {"@type": "Answer", "text": "A direct integration vendor builds and maintains point-to-point connections to specific EHR instances, offering higher data fidelity but higher maintenance overhead. An aggregator maintains a broad pre-built network and exposes a unified API, offering faster access but with data quality and freshness that varies by underlying source."}
    },
    {
      "@type": "Question",
      "name": "Why does TEFCA participation matter for vendor selection?",
      "acceptedAnswer": {"@type": "Answer", "text": "TEFCA and QHIN participation require passing a formal onboarding and security review process through the Sequoia Project's Recognized Coordinating Entity role, making it a more verifiable maturity signal than a vendor's own connectivity claims. It also determines which permitted exchange purposes your queries can actually support."}
    },
    {
      "@type": "Question",
      "name": "Is FHIR R4 support enough, or do we need to verify more?",
      "acceptedAnswer": {"@type": "Answer", "text": "FHIR R4 support alone isn't sufficient verification. Confirming US Core profile conformance for the specific resources your product uses, ideally backed by a documented Inferno test suite pass, is necessary since generic \"FHIR support\" claims often mask partial or non-standard resource implementations."}
    },
    {
      "@type": "Question",
      "name": "How do Da Vinci implementation guides relate to standard FHIR?",
      "acceptedAnswer": {"@type": "Answer", "text": "Da Vinci implementation guides are built on top of base FHIR but add payer-specific resource profiles and workflow constraints for use cases like prior authorization and coverage data exchange. General FHIR competency doesn't automatically mean a vendor supports specific Da Vinci guides at a usable conformance level."}
    },
    {
      "@type": "Question",
      "name": "What happens to our integration if we switch interoperability vendors later?",
      "acceptedAnswer": {"@type": "Answer", "text": "Portability depends on whether the vendor exposed genuinely standard FHIR resources or a proprietary data model layered on top of FHIR. This should be asked about directly before committing, since a proprietary abstraction layer can make switching vendors later far more expensive than the initial integration suggested."}
    }
  ]
}
</script>
